The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
Kris Garcia, a husband, father of four, and a P4AD patient advocate from Colorado introduced the President at the White House on Wednesday during an event hosted by President Biden and Senator…
News Mar 29, 2024On Tuesday, the Department of Health & Human Services (HHS) announced a list of 41 drugs available through Medicare Part B will have a lower coinsurance rate from April 1 – June 30, 2024, should drug…
News Mar 22, 2024Big drug companies continue to drum up bold lies regarding the impact of the drug price reforms in the Inflation Reduction Act (IRA).
News Mar 15, 2024Key Senators remain committed to advancing bipartisan bills aimed at cracking down on pharmacy benefit managers (PBMs) and their opaque tactics, which drive up costs for patients and taxpayers.
News Mar 11, 2024In a week marked by significant developments in the fight to make medicine more affordable, Patients For Affordable Drugs Now (P4ADNow) applauded President Biden’s ongoing commitment to reducing drug…
News Mar 2, 2024Yesterday, a federal judge in Delaware delivered a significant blow to AstraZeneca by ruling against the company in its effort to halt the negotiation of its diabetes drug, Farxiga, marking a pivotal…
News Feb 23, 2024It’s been 18 months since the passage of the Inflation Reduction Act and we’re still buzzing about the drug price reforms that are helping millions of patients see cost savings.
News Feb 16, 2024Marking an important step in protecting Medicare’s ability to negotiate lower prices for millions of patients, a Texas federal judge dismissed the lawsuit from trade association Pharmaceutical…
News Feb 9, 2024Senators Peter Welch and Amy Klobuchar were joined by patient advocates and health care experts for a panel discussion on Big Pharma’s use of patent thickets to extend market exclusivity and the new…
News Feb 2, 2024As part of the sweeping reforms to lower prescription drug costs for millions of patients, the Centers For Medicare and Medicaid Services (CMS) sent initial price offers to drug manufacturers for the…